Palisade Bio Inc reports results for the quarter ended in September - Earnings Summary

Palisade Bio

14/11/2022 18:02

* Palisade Bio Inc  PALI.OQ  reported a quarterly adjusted
loss
of 8 cents​​ per share for the quarter ended in September. The
mean expectation of two analysts for the quarter was for a loss
of 8 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Palisade Bio Inc's reported EPS for the quarter was a loss
of 8
cents​.
    * The mean earnings estimate of analysts had risen by
about 27.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Palisade Bio Inc shares had fallen by 17.3% this
quarter and
lost 93.7% so far this year.
    * The company reported a quarterly loss of $3.99 million.
    * Wall Street's median 12-month price target for Palisade
Bio Inc
is $1.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 06:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.08          -0.08          Met
 Jun. 30 2022      -0.17          -0.12          Beat
 Mar. 31 2022      -0.28          -0.26          Beat
 Dec. 31 2021      -0.23          0.08           Beat